AMBOSS, founded in 2012, is a pioneering medical technology company headquartered in Germany. The company is known for its slogan, "Empowering medical professionals to provide the best possible care," reflecting its commitment to enhancing healthcare delivery globally.
AMBOSS operates a comprehensive knowledge platform that revolutionizes how medical information is accessed and used by both students and clinicians. With a focus on high-impact learning, students utilize its interactive library and question bank for efficient study and exam prep, while clinicians make informed decisions with its evidence-based recommendations. Its international team, composed of over 400 experts, underscores the company's robust dedication to the health sector.
The company recently secured a significant €240.00M Late VC investment on 01 March 2025, with participation from investors such as Lightrock, KIRKBI, Partech, and M&G. This injection of capital positions AMBOSS to further expand its global footprint and technological capabilities, currently serving over a million healthcare professionals in more than 180 countries. As it stands, AMBOSS is a prime candidate for investors seeking to contribute to innovative solutions in the education and healthcare sectors.